CV Sciences (CVSI) Asset Writedowns and Impairment (2013 - 2020)

CV Sciences (CVSI) reported Asset Writedowns and Impairment of $6.2 million for Q4 2020, up 3031.31% on a YoY basis from $198000.0 in Q1 2020, and up 3031.31% sequentially from $198000.0 in Q4 2019.

CV Sciences (CVSI) Asset Writedowns and Impairment (2013 - 2020) Analysis & Trends

CV Sciences (CVSI) has 7 years of Asset Writedowns and Impairment data on file, last reported at $6.2 million in Q4 2020.

  • For the quarter ending Q4 2020, Asset Writedowns and Impairment rose 3031.31% year-over-year to $6.2 million; the trailing twelve-month figure through Dec 2020 stood at $6.4 million (up 2613.56% YoY), and the FY2023 full-year result was $251000.0, down 79.66% from the prior year.
  • Asset Writedowns and Impairment grew to $6.2 million in Q4 2020, from $198000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $6.2 million in Q4 2020 to a low of -$47000.0 in Q4 2018.
  • A 5-year average of $631384.2 and a median of $32000.0 in 2019 frame the typical range for Asset Writedowns and Impairment.
  • Across the five-year window, Asset Writedowns and Impairment sank 156.92% in 2018 and soared 3300.0% in 2019, its largest moves.
  • Tracing CVSI's Asset Writedowns and Impairment over 5 years: stood at $31003.0 in 2016, then jumped by 166.31% to $82565.0 in 2017, then slumped by 156.92% to -$47000.0 in 2018, then soared by 521.28% to $198000.0 in 2019, then soared by 3031.31% to $6.2 million in 2020.
  • Business Quant data shows CVSI's Asset Writedowns and Impairment at $6.2 million in Q4 2020, $198000.0 in Q4 2019, and $6000.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.78 Bn 87.91 Bn -
2 Teva Pharmaceutical Industries 35.95 Bn 32.20 Bn 1.97 Bn
3 Zoetis 32.50 Bn 30.56 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn
5 United Therapeutics 23.01 Bn 20.85 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.41 Bn 18.61 Bn 1.16 Bn
8 Neurocrine Biosciences 17.77 Bn 16.45 Bn 800.70 Mn
9 Elanco Animal Health 12.66 Bn 12.23 Bn 785.00 Mn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 6.20 Mn
Dec 31, 2020 6.20 Mn
Dec 31, 2019 198,000.00
Dec 31, 2019 198,000.00
Sep 30, 2019 6,000.00
Sep 30, 2019 6,000.00
Jun 30, 2019 32,000.00
Jun 30, 2019 32,000.00
Dec 31, 2018 -47,000.00
Dec 31, 2018 -47,000.00
Sep 30, 2018 40,223.00
Sep 30, 2018 40,223.00
Jun 30, 2018 -1,000.00
Jun 30, 2018 -1,000.00
Mar 31, 2018 3,000.00
Mar 31, 2018 3,000.00
Dec 31, 2017 82,565.00
Dec 31, 2017 82,565.00
Jun 30, 2017 400,435.00
Jun 30, 2017 400,435.00